In human studies, it has been demonstrated that serum fetuin-B was increased in humans with liver steatosis (12), patients with T2D, women with gestational diabetes mellitus (GDM) (13), as well as in patients with coronary artery disease, in comparison to healthy controls (14). Here, FETUB is linked to type 2 diabetes mellitus.